Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Nov;145(11):2811-2827.e8.
doi: 10.1016/j.jid.2025.03.033. Epub 2025 Apr 9.

T Cells Promote Distinct Transcriptional Programs of Cutaneous Inflammatory Disease in Keratinocytes and Dermal Fibroblasts

Affiliations

T Cells Promote Distinct Transcriptional Programs of Cutaneous Inflammatory Disease in Keratinocytes and Dermal Fibroblasts

Hannah A DeBerg et al. J Invest Dermatol. 2025 Nov.

Abstract

T cells and structural cells coordinate appropriate inflammatory responses and restoration of barrier integrity following insult. Dysfunctional T cells precipitate skin pathology occurring alongside altered structural cell frequencies and transcriptional states, but to what extent different T cells promote disease-associated changes remains unclear. We show that functionally diverse circulating and skin-resident CD4+CLA+ T-cell populations promote distinct transcriptional outcomes in human keratinocytes and fibroblasts associated with inflamed or healthy tissue. We identify T helper 17 cell-induced genes in keratinocytes that are enriched in psoriasis patient skin and normalized by anti-IL-17 therapy. We also describe a CD103+ skin-resident T-cell-induced transcriptional module enriched in healthy controls that is diminished during psoriasis and scleroderma and show that CD103+ T-cell frequencies are altered during disease. Interrogating clinical data using immune-dependent transcriptional signatures defines the T-cell subsets and genes distinguishing inflamed from healthy skin and allows investigation of heterogeneous patient responses to biologic therapy.

Keywords: Atopic dermatitis; CD4 T cells; Psoriasis; Scleroderma; Skin inflammation.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST STATEMENT

The authors declare no competing interests.

Update of

References

    1. Aboobacker S, Kurn H, Al Aboud AM. Secukinumab. StatPearls, Treasure Island (FL): StatPearls Publishing; 2024. - PubMed
    1. Ågren MS, Chafranska L, Eriksen JO, Forman JL, Bjerrum MJ, Schjerling P, et al. Spatial expression of metallothionein, matrix metalloproteinase-1 and Ki-67 in human epidermal wounds treated with zinc and determined by quantitative immunohistochemistry: A randomised double-blind trial. Eur J Cell Biol 2021;100:151147. 10.1016/j.ejcb.2020.151147. - DOI - PubMed
    1. Bangert C, Rindler K, Krausgruber T, Alkon N, Thaler FM, Kurz H, et al. Persistence of mature dendritic cells, TH2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4Rα blockade. Sci Immunol 2021;6:eabe2749. 10.1126/sciimmunol.abe2749. - DOI - PubMed
    1. Bertelsen T, Ljungberg C, Litman T, Huppertz C, Hennze R, Rønholt K, et al. IκBζ is a key player in the antipsoriatic effects of secukinumab. J Allergy Clin Immunol 2020;145:379–90. 10.1016/j.jaci.2019.09.029. - DOI - PubMed
    1. Bieber T Interleukin-13: Targeting an underestimated cytokine in atopic dermatitis. Allergy 2020;75:54–62. 10.1111/all.13954. - DOI - PubMed

MeSH terms

LinkOut - more resources